Literature DB >> 12220797

Predictors of willingness to consider medication and psychosocial treatment for panic disorder in primary care patients.

Holly Hazlett-Stevens1, Michelle G Craske, Peter P Roy-Byrne, Cathy D Sherbourne, Murray B Stein, Alexander Bystritsky.   

Abstract

The purpose of this investigation was to identify demographic and clinical patient characteristics related to willingness to consider panic disorder treatments in the primary care setting. Given the prevalence of anxiety disorders and the increased provision of mental health treatments in general medical settings, patients were selected from primary care settings. An unselected sample of 4,198 patients completed a brief questionnaire containing questions about demographic characteristics, physical health status, and symptoms of panic disorder, social phobia and PTSD. The 1,043 patients indicating a recent panic attack episode answered additional questions about their willingness to consider both medication and psychosocial forms of intervention for panic. Of these panic patients, 64% reported willingness to consider medication and 67% reported willingness to consider a psychosocial intervention for their panic. Logistic regression analyses for these panic patients revealed that willingness to consider medication treatment for panic was associated with older age, lower education, poorer health status and the presence of social phobia and/or PTSD symptoms. In addition, Asian and African American patients were less likely than Caucasian patients to indicate willingness to consider medication treatment for their panic. However, only the presence of comorbid social phobia and PTSD symptoms predicted willingness to consider a psychosocial intervention. Results suggest that acceptability of psychosocial treatment is unrelated to demographic and physical health factors, while primary care patients with certain demographic characteristics, good physical health, or who suffer from fewer comorbid mental health conditions may need additional encouragement to begin medication treatment for panic.

Entities:  

Mesh:

Year:  2002        PMID: 12220797     DOI: 10.1016/s0163-8343(02)00204-9

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  18 in total

1.  Do You Need To Talk About It? Prolonged Exposure for the Treatment of Chronic PTSD.

Authors:  Afsoon Eftekhari; Lisa R Stines; Lori A Zoellner
Journal:  Behav Anal Today       Date:  2006-01-01

2.  Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial.

Authors:  Peter Roy-Byrne; Michelle G Craske; Greer Sullivan; Raphael D Rose; Mark J Edlund; Ariel J Lang; Alexander Bystritsky; Stacy Shaw Welch; Denise A Chavira; Daniela Golinelli; Laura Campbell-Sills; Cathy D Sherbourne; Murray B Stein
Journal:  JAMA       Date:  2010-05-19       Impact factor: 56.272

3.  A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder.

Authors:  Peter P Roy-Byrne; Michelle G Craske; Murray B Stein; Greer Sullivan; Alexander Bystritsky; Wayne Katon; Daniela Golinelli; Cathy D Sherbourne
Journal:  Arch Gen Psychiatry       Date:  2005-03

4.  Relationships between personal beliefs and treatment acceptability, and preferences for behavioral treatments.

Authors:  Souraya Sidani; Joyal Miranda; Dana R Epstein; Richard R Bootzin; Jennifer Cousins; Patricia Moritz
Journal:  Behav Res Ther       Date:  2009-06-24

5.  The Composite International Diagnostic Interview (CIDI-Auto): problems and remedies for diagnosing panic disorder and social phobia.

Authors:  Adrienne Means-Christensen; Cathy D Sherbourne; Peter Roy-Byrne; Michelle G Craske; Alexander Bystritsky; Murray B Stein
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

6.  Providing a treatment rationale for PTSD: does what we say matter?

Authors:  Norah C Feeny; Lori A Zoellner; Shoshana Y Kahana
Journal:  Behav Res Ther       Date:  2009-06-21

7.  What you believe is what you want: modeling PTSD-related treatment preferences for sertraline or prolonged exposure.

Authors:  Lori A Zoellner; Norah C Feeny; Joyce N Bittinger
Journal:  J Behav Ther Exp Psychiatry       Date:  2009-06-12

8.  Predictors of clinical improvement in a randomized effectiveness trial for primary care patients with panic disorder.

Authors:  Denise A Chavira; Murray B Stein; Daniela Golinelli; Cathy D Sherbourne; Michelle G Craske; Greer Sullivan; Alexander Bystritsky; Peter P Roy-Byrne
Journal:  J Nerv Ment Dis       Date:  2009-10       Impact factor: 2.254

9.  "How will it help me?" Reasons underlying treatment preferences between sertraline and prolonged exposure in posttraumatic stress disorder.

Authors:  Jessica A Chen; Stephanie M Keller; Lori A Zoellner; Norah C Feeny
Journal:  J Nerv Ment Dis       Date:  2013-08       Impact factor: 2.254

10.  The effects of positive patient testimonials on PTSD treatment choice.

Authors:  Larry D Pruitt; Lori A Zoellner; Norah C Feeny; Daniel Caldwell; Robert Hanson
Journal:  Behav Res Ther       Date:  2012-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.